Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Cut by Umpqua Bank

Umpqua Bank lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,942 shares of the medical equipment provider’s stock after selling 174 shares during the quarter. Umpqua Bank’s holdings in Intuitive Surgical were worth $1,445,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Creekmur Asset Management LLC grew its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in Intuitive Surgical during the second quarter valued at about $26,000. Delos Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares in the last quarter. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. Finally, LRI Investments LLC bought a new position in shares of Intuitive Surgical in the 1st quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now directly owns 821 shares of the company’s stock, valued at $402,519.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 240 shares of the company’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $464.76, for a total value of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,558,968.56. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 68,246 shares of company stock valued at $33,839,308 in the last 90 days. 0.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ISRG. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Raymond James raised their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $2.33 during trading hours on Wednesday, hitting $517.50. The company had a trading volume of 120,985 shares, compared to its average volume of 1,449,791. Intuitive Surgical, Inc. has a 12 month low of $269.49 and a 12 month high of $525.00. The firm’s fifty day moving average is $491.63 and its 200 day moving average is $449.59. The firm has a market capitalization of $184.32 billion, a price-to-earnings ratio of 82.82, a PEG ratio of 4.98 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.